Besponsa (inotuzumab ozogamicin)

pCPA File Number: 21057
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute Lymphoblastic Leukemia (ALL)
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
PC0121-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: